Sort
82,697 grants matching “vaccine development”
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing
$784,845Kit S Lam · University Of California At Davis · UG3 · FY2021 · TR
Anti-flavivirus B cell response analysis to aid vaccine design
$784,842Yuxing Li · University Of Maryland Baltimore · R01 · FY2023 · AI
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTG
$784,832David Eric Shapiro · Harvard School Of Public Health · U01 · FY2009 · AI
Baylor College of Medicine Clinical Trial Unit
$784,766William Thomas Shearer · Baylor College Of Medicine · U01 · FY2010 · AI
Generation and Function of NK Cell Memory
$784,741Ulrich H Von Andrian · Harvard Medical School · R01 · FY2013 · AI
Novel Pathogen Associated Cancers (PQ12)
$784,723Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Toxoplasma Surface Antigens and Immunity
$784,656Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
New Approaches To Active Immunoprophylaxis
$784,647Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
DEVELOPMENT OF A PRIMATE GENOMICS RESOURCE
$784,589Michael G Katze · University Of Washington · R24 · FY2007 · RR
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$784,554Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2013 · AI
Malaria Vaccine: Pfs25-Pvs25
$784,546Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development
$784,546Thomas Denny · Duke University · N01 · FY2022 · AI
Malaria Vaccine: AMA1-rEPA
$784,546Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination
$784,531Sara Lustigman · New York Blood Center · U01 · FY2017 · AI
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
$784,517Erol Fikrig · Yale University · R01 · FY2025 · AI
Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
$784,482Jonathan S Lewin · Emory University · P51 · FY2021 · OD
Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry
$784,475Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2024 · AI
Clinical Trials of Biodefense Vaccines (Dengue)
$784,454Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$784,398Stephanie Jost · Duke University · R01 · FY2022 · AI
Disabling Vaccinia IFNr: A New Smallpox Vaccine
$784,358Bertram L. Jacobs · Arizona State University-Tempe Campus · U01 · FY2008 · AI
Mali International Center for Excellence in Research: Malaria and Vectors
$784,357Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Integrated genomics research in parasitic tropical diseases
$784,316Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2014 · AI
Translational Geroscience Network
$784,286James L. Kirkland · Mayo Clinic Rochester · R33 · FY2023 · AG
Modulation of innate and adaptive immunity of filoviruses in macaques
$784,263Thomas William Geisbert · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Biomolecule Production
$784,167Robin A Ross · Harvard Medical School · U54 · FY2013 · AI